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Abstract
The glycoprotein (GP) of lymphocytic choriomeningitis virus (LCMV) serves as virus attachment protein to its receptor on host cells
and is a key determinant for cell tropism, pathogenesis, and epidemiology of the virus. The GP of LCMV is posttranslationally cleaved by
the subtilase SKI-1/S1P into two subunits, the peripheral GP1, which is implicated in receptor binding, and the transmembrane GP2 that
is structurally similar to the fusion active membrane proximal portions of the glycoproteins of other enveloped viruses. The present study
shows that cleavage by SKI-1/S1P is not required for cell surface expression of LCMVGP on infected cells but is essential for its
incorporation into virions and for the production of infectious virus particles. In absence of SKI-1/S1P cleavage, cell-to-cell propagation of
the virus was markedly reduced. Further, proteolytic processing of LCMVGP depends on the presence of a cluster of basic amino acids at
the C-terminus of the cytoplasmic domain of GP2, a structural motif that is conserved in Old World arenaviruses. The effect of the truncation
of the cytoplasmic tail on cleavage suggests a structural interdependence between the cytoplasmic domain and the ectodomains of
LCMVGP.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Lymphocytic choriomeningitis virus (LCMV) is the pro-
totypic member of the arenavirus family (Southern et al.,
1996) and its infection of its natural host, the mouse, has
provided novel concepts in immunology and virology that
have been extended to other RNA as well as DNA viruses,
bacteria, and parasites (Zinkernagel, 2001; Oldstone, 2001).
Its bisegmented negative-strand genome consists of two
single-stranded RNA species: the 2larger (L) segment en-
codes the virus polymerase (L) and a small zinc finger motif
protein (Z); the smaller (S) segment encodes the virus nu-
cleoprotein (NP) and glycoprotein (GP) precursor (GPC).
The envelope GP of LCMV is coded by the 5 end of the
viral S RNA and is proteolytically processed into two prod-
ucts, the peripheral GP1 (44 kDa), which forms 5–10-nm-
long surface projections (spikes) at the virion surface and
the transmembrane GP2 (35 kDa) (Buchmeier and Old-
stone, 1979). Initial biochemical analysis by Burns and
Buchmeier (1991) suggested a heterotetrameric structure for
LCMVGP in which tetramers of the transmembrane GP2
are associated noncovalently with tetramers of GP1. The
GP1 portion of the GP spike mediates the virus-receptor
interaction based on the fact that neutralizing antibodies that
block viral binding are formed exclusively against GP1
(Parekh and Buchmeier, 1986; Borrow and Oldstone, 1992).
GP1 is heavily glycosylated, with carbohydrates accounting
for 30% of its apparent molecular mass. GP2 is structurally
similar to the fusion active membrane proximal portions of
the GP of other enveloped viruses (Gallaher et al., 2001).
The cytoplasmic domain of GP2 shows a high degree of
sequence conservation among Old World arenaviruses.
Upon receptor binding, arenavirus virions are internalized
by uncoated vesicles and released into the cytoplasm by a
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pH-dependent membrane fusion step (Borrow and Old-
stone, 1994; Di Simone et al., 1994; Di Simone and Buch-
meier, 1995).
Recent studies revealed that the GP precursor of Lassa
fever virus (LFV), which is structurally closely related to
LCMVGP, is cleaved at the recognition site RRLL by the
protease subtilase SKI-1/S1P (Lenz et al., 2001), an enzyme
involved in cholesterol metabolism (Sakai et al., 1998).
Cleavage of LFVGP by SKI-1/S1P occurs in the endoplas-
matic reticulum (ER) and is essential for incorporation of
LFVGP into virion particles and the generation of infectious
virus. LCMVGP that contains a closely related cleavage site
(RRLA) is also cleaved by SKI-1/S1P (Beyer et al., 2003,
this study). In contrast to LFVGP, cleavage of LCMVGP
occurs later in the secretory pathway, in a late-Golgi or
post-Golgi compartment (Wright et al., 1990; Beyer et al.,
2003).
The present study shows that cleavage by SKI-1/S1P is
not required for cell surface expression of LCMVGP on
infected cells but is essential for three steps of LCMV
replication including, first, GP incorporation into virions,
second, the production of infectious virus particles, and,
third, cell-to-cell propagation of virus. Further, cleavage
critically depends on structures within the cytoplasmic do-
main of GP2, in particular on a conserved cluster of basic
amino acids at the C-terminus of GP2, suggesting a struc-
tural interdependence between the cytoplasmic domain and
the ectodomain of LCMVGP.
Results
Cleavage of LCMVGP by the subtilase SKI-1/S1P is
essential for incorporation into virions and the production
of infectious virus particles
Since LCMV virions are assembled at the plasma mem-
brane of infected cells, we addressed the role of proteolytic
cleavage for cell surface expression of LCMVGP and its
incorporation into virions. To this end, we studied the pres-
ence of GP precursor (GPC) and of mature, cleaved GP in
the plasma membrane of infected cells as well as in released
virions. Vero cells were infected with LCMV ARM53b at
low multiplicity of infection (MOI). Forty hours post infec-
tion, cell surface proteins were specifically labeled by using
the membrane-impermeable biotinylation reagent NHS-X-
biotin and recovered from total cell lysates by streptavidin-
agarose (Gonzalez-Dunia et al., 1997). Biotin-labeled pro-
teins and total cell protein were then analyzed by
immunoblotting using monoclonal antibody 83.6 anti-LC-
MVGP, which recognizes a highly conserved epitope
present in both, GPC and mature GP2 (Weber and Buch-
meier, 1988). Specificity of the cell surface labeling was
shown by insignificant biotin-labeling of the intracellular
protein -tubulin (Fig. 1A). Western blot analysis revealed
biotin labeling of 10% of total cellular LCMVGP. The
biotinylated protein fraction contained primarily cleaved,
but also uncleaved GP (Fig. 1A). To address the question
whether uncleaved GP was incorporated into virion parti-
cles, supernatants from infected cells were subjected to
ultracentrifugation through a 20% sucrose cushion, and pel-
lets analyzed by Western blot. In contrast to the situation at
the surface of infected cells, no uncleaved GP was detected
in virion particles (Fig. 1B), indicating that only the cleaved
form of GP was incorporated into LCMV virions.
Both our investigations and a recent study by Beyer et al.
(2003) demonstrated cleavage of LCMVGP by the sub-
tilase SKI-1/S1P. We therefore addressed the relevance of
SKI-1/S1P cleavage for cell surface expression of LCMVGP
in infected cells, its incorporation into virions, and the
production of infectious virus. For these studies, we used
the S1P-deficient cell line SRD12B and its parental cell line
CHOK1 (Rawson et al., 1998). Consistent with the report of
Beyer et al. (2003), LCMVGP synthesized by SRD12B
cells, either as a recombinant protein or during virus infec-
Fig. 1. Detection of lymphocytic choriomeningitis virus glycoprotein
(LCMVGP) at the surface of infected cells and in virions. (A) Cell surface
biotinylation of LCMVGP in infected cells. Vero cells were infected with
LCMV ARM53b at a multiplicity of infection (MOI) of 0 (lane 1), 0.001
(2), 0.01 (3), and 0.1 (4). Forty hours after infection, cell surface protein
was labeled with biotin-X-NHS and the surface-labeled cells subsequently
lysed. Fifty percent of the lysate were subjected to affinity precipitation
with streptavidin-agarose. From the remaining 50% total protein was iso-
lated. Streptavidin-precipitated proteins and total protein were then sepa-
rated by sodium dodecyl sulfate–polyacrylamide gel electrophorosis (SDS-
PAGE), transferred to nitrocellulose, and analyzed by Western blot using
monoclonal antibody (mAb) 83.6 anti-LCMVGP (upper gel) and mAb
DM1A anti--tubulin (lower gel). Primary antibodies were detected with
peroxidase-conjugated secondary antibodies by using enhanced chemilu-
minescence for detection. Positions of GPC, GP2, and -tubulin (-tu) are
indicated. The arrow indicates GPC detected in biotinylated proteins. For
the infection with MOI  0.1 (lanes 4), the intensity of the bands for GPC
(IGPC) and GP2 (IGP2) were determined by densitometry. The calculated
ratios of IGPC/IGP2 for the biotinylated protein fraction and for total protein
are indicated. (B) Detection of LCMVGP in virions. Vero cells were
infected with LCMV ARM53b at an MOI of 0.01 (lane 1) and 0.1 (2). After
40 h, LCMV virions were precipitated from the supernatant and purified by
ultracentrifugation on a renografin gradient. After dialysis against phos-
phate-buffered saline, virions were solubilized in SDS-PAGE sample
buffer. Proteins were separated by SDS-PAGE and subjected to Western
blot analysis as in A.
169S. Kunz et al. / Virology 314 (2003) 168–178
tion was not processed (Fig. 2A). Production of infectious
virus was markedly reduced in SRD12B cells (Fig. 2B). To
exclude the possibility that a block in LCMV replication
unrelated to SKI-1/S1P deficiency prevents production of
infectious virus in SRD12B cells, we analyzed the function
of LCMVGP produced by these cells. For this purpose, we
incorporated recombinant LCMVGP produced in SRD12B,
CHOK1, and COS1 cells into retroviral vectors derived
from Moloney leukemia virus (MLV) that carry an EGFP
reporter gene in their genome (Soneoka et al., 1995; Miletic
et al., 1999). Since these pseudotyped retroviral vectors
(MLV-PS) acquire the host range of the virus from which
the heterologous GP is derived (Sutton and Littman, 1996;
Wool-Lewis and Bates, 1998), biological activity of the
recombinant LCMVGP can be assessed by a reporter gene-
based infection assay. MLV-PS containing recombinant
LCMVGP or the glycoprotein of vesicular stromatitis virus
(VSV) were generated in SRD12B, CHOK1, and COS1
cells as described in the materials and methods section. The
infectivity of the MLV-PS was tested on monolayers of
Vero cells. We found efficient infection with MLV-PS con-
taining LCMVGP and VSVGP that had been produced in
CHOK1 and COS1 cells (Fig. 2C), indicating correct bio-
chemical processing, transport, and biological activity of
recombinant protein. In contrast, MLV-PS containing re-
combinant LCMVGP produced by SRD12B cells failed to
show significant infectivity while control MLV-PS pseudo-
typed with VSVGP synthesized by the same cells were
functional (Fig. 2C). These results pinpoint the lack of GPC
cleavage by SKI-1/S1P as responsible for the loss of function.
Fig. 2. Cleavage of lymphocytic choriomeningitis virus glycoprotein (LCMVGP) by the subtilase SKI-1/S1P is required for its incorporation into virions.
(A) SKI-1/S1P is essential for cleavage of LCMVGP. S1P-deficient SRD12B and control CHOK1 cells were infected with LCMV ARM53b (LCMV
infection) at a multiplicity of infection (MOI) of 0 (lane 1), 0.1 (lane 2), and 1 (lane 3) or transfected (Recombinant LCMVGP) with the expression construct
pC-LCMVGP (lane 1) and pC-EGFP (lane 2) using lipofectamine. Two days after infection or transfection, cells were lysed in sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) sample buffer, proteins separated by SDS-PAGE and probed for LCMVGP by Western-blot as
described in Fig. 1. Molecular mass standards are indicated. (B) LCMV production depends on cleavage of LCMVGP by SKI-1/S1P. SRD12B (black bars),
CHOK1 cells (white bars), and BHK-21 cells (gray bars) were infected with LCMV ARM53b at an MOI of 0.1. Supernatants of infected cells were analyzed
at 24, 48, and 72 h post infection for virus content by plaque titration on Vero cells (n  3; SD). (C) LCMVGP produced by S1P-deficient SRD12B cells
is not biologically active. SRD12B, CHOK1, and COS1 cells were cotransfected with the expression plasmids pC-LCMVGP (black bars) or and pC-VSVGP
(white bars) in combination with a plasmid containing the Moloney leukemia virus (MLV) gag and pol genes and a plasmid containing an MLV genome
with an enhanced green fluorescent protein (EGFP) reporter gene. Fourty-eight hours after cotransfection, MLV-PS were harvested and titers determined on
Vero cells by serial dilutions of supernatants (n  3; SD). (D) Cleavage of LCMVGP by SKI-1/S1P is required for its incorporation into virions. Virions
from supernatants of SRD12B (S) and CHOK1 (C) cells infected with LCMV ARM53b at a MOI of 1 were isolated by ultracentrifugation through a sucrose
cushion. Virion protein was solubilized, separated by SDS-PAGE, and transferred to nitrocellulose. For the detection of LCMVGP (anti-GP), blots were
probed with monoclonal antibody (mAb) 83.6 as described in Fig. 1. For detection of LCMVNP, membranes were probed with a guinea pig polyclonal
anti-LCMV serum, using a peroxidase-conjugated secondary antibody and enhanced chemiluminescence for detection. Purified LCMV ARM53b produced
in BHK-21 cells was used as a positive control () and a supernatant of uninfected Chnese hamster ovary (CHO) cells as a negative control (). Molecular
masses and positions of GPC, GP2, and NP are indicated.
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Since the LCMV titers obtained from infected SRD12B
cells were consistently four to five orders of magnitude
lower than those obtained from CHOK1 cells (Fig. 2B), we
addressed the question of whether noninfectious virus par-
ticles were released from SRD12B cells. The culture super-
natants of infected SRD12B and CHOK1 cells were sub-
jected to ultracentrifugation through a 20% sucrose cushion
and isolated particles analyzed by Western blot for the
presence of NP and GP. While NP was detected in pellets
from supernatants of SRD12B and CHOK1 cells (Fig. 2D),
LCMVGP was detected only in particles from supernatants
of CHOK1 cells but not in those isolated from supernatants
of SRD12B cells. Again, only cleaved GP was detected in
virions released from infected CHOK1 cells (Fig. 2D). The
amount of NP detected in supernatants from SRD12B cells
was circa 10-fold lower than the amount detected in super-
natants from CHOK1 cells. Together with the reduced
amounts of GP detected in lysates of SRD12B cells com-
pared to CHOK1 cells (Fig. 2A), the data indicate a limited
extent of infection in these cultures. Since our detection
method for GP is more sensitive than that for NP (compare
signal intensity between GP and NP in blots of Fig. 2D), the
absence of GP from particles released by SRD12B cells
indicates a significant reduction in their GP/NP ratio com-
pared to the particles released by CHOK1 cells. The reduced
GP/NP ratio in virions released from SRD12B cells may be
either due to inefficient cell surface expression of LCMVGP
in these cells or because cleavage of GP is required for its
efficient incorporation into virions.
Cell surface expression of LCMVGP in infected cells can
occur in the absence of SKI-1/SP1 cleavage
To address the question whether the reduction in the
GP/NP ratio in particles released by SRD12B cells (Fig. 2D)
is due to reduced cell surface expression of GP, we infected
SRD12B and CHOK1 cells with different MOI of LCMV
and analyzed cell surface expression of GP after 48 h by
flow cytometry. The extent of LCMV infection in the cul-
tures was quantitatively assessed by intracellular staining
for LCMVNP and flow cytometry as described (Sevilla et
al., 2000). Consistent with the Western blot data (Fig. 2A),
flow cytometry revealed only a low percentage of infected
SRD12B cells expressing LCMVNP compared to CHOK1
cells (Fig. 3A). The limited extent of infection in these
cultures 48 h post infection may be explained by the lack of
cell-to-cell spread of the virus, most probably due to the
strongly reduced titers of infectious virions (Fig. 2B). As
expected, high infection levels were obtained with CHOK1
cells after 48 h, even after infection with low MOI (Fig.
3A), indicating efficient cell-to-cell propagation of the in-
fection. Cell surface staining for GP in CHOK1 cells closely
correlated with the intracellular staining for NP (Fig. 3B),
demonstrating high sensitivity and specificity of cell surface
labeling of GP. Despite the absence of GP cleavage, as
demonstrated by Western blot (Fig. 2A), significant cell
surface expression of GP was detected on infected SRD12B
cells (Fig. 3B). The extent of cell surface expression of GP
correlated with intracellular staining for LCMVNP (Fig. 3A
and B), indicating that cleavage by SKI-1/S1P is not re-
quired for transport of LCMVGP to the surface of infected
cells. Together, these findings indicate that SKI-1/S1P
cleavage is not essential for cell surface expression of GP in
infected cells but is required for the efficient incorporation
of GP into virions, production of infectious virus, and cell-
to-cell propagation of infection.
The cytoplasmic domain of GP plays a crucial role for
cleavage of LCMVGP
As proteolytic cleavage represents an essential step in the
biosynthesis of functional LCMVGP, the identification of
structural elements that influence this process is of interest.
Studies with several other viral glycoproteins have shown
that alterations in the cytoplasmic domains can have pro-
found effects on ectodomain structure and function. To
determine the potential role of the cytoplasmic domain of
LCMVGP for virus function, we constructed the following
LCMVGP variants: LCMVGPD1 that contained a deletion
of amino acids 462–498 and LCMVGPD2 that lacked the
C-terminal sequence KRR (amino acids 496–498) (Fig.
4A). The cDNA sequences of LCMVGPD1 and LCM-
VGPD2 were inserted into the expression vector pcAGGS
and the mutants transiently expressed in COS1 cells, with
wild-type LCMVGP as a positive control. As a noncleav-
able control, the LCMVGP mutant LCMVGRRAA that
contains the point mutations R262A/R263A within the SP1
recognition site RRLA (D.D. Pinschewer and J.C. de la
Torre, unpublished data) was used. Western blot analysis of
total cell protein revealed similar expression levels for all
LCMVGP variants. Both deletion mutants, LCMVGPD1
and LCMVGPD2, and the noncleavable mutant LCMVG-
PRRAA were not processed whereas normal cleavage was
observed with the wild-type GP (Fig. 4B). The band be-
tween GPC and GP2 in the Western blot in Fig. 4B is most
probably unprocessed GPC precursor that accumulates ei-
ther due to lower activity of SKI-1/S1P protease in COS1
cells or to higher expression levels of recombinant GP.
The marked reduction of GP cleavage due to the cyto-
plasmic deletions suggests a strong impact of these muta-
tions on the function of LCMVGP. Considering the limited
sensitivity of Western blot analysis, we next used a more
sensitive assay to assess the loss of function of the
LCMVGP mutants. Since the retroviral pseudotype system
allows the detection of small residual activity in a sensitive
reporter gene assay, the LCMVGP mutants and wild-type
LCMVGP were incorporated into MLV virions and the
resulting MLV-PS tested in an infection assay as described
above. None of the LCMVGP mutants was significantly
active by this assay (Fig. 4C), indicating that loss of func-
tion was due to the deletions made. To further address the
impact of the cytoplasmic deletions on cell surface expres-
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sion of LCMVGP, we performed flow cytometry analysis
on COS1 cells transiently transfected with LCMVGPD1,
LCMVGPD2, LCMVGPRRAA, and wild-type LCMVGP.
Cell surface labeling of GP revealed comparable surface
expression with all variants (Fig. 5). Deletion or truncation
of the cytoplasmic domain, despite their dramatic impact on
cleavage, had no significant effect on transport and cell
surface expression of GP. These findings indicate a crucial
role of the cytoplasmic domain of GP for the proper folding
and processing of the ectodomain, but not for its transport
and cell surface expression.
Discussion
This study presents three main points. First, proteolytic
cleavage by the subtilase SKI-1/S1P is not essential for cell
surface expression of LCMVGP in infected cells but is
required for its incorporation into virions, the production of
infectious virus, and cell-to-cell spread of infection. Second,
proteolytic processing of LCMVGP critically depends on
the presence of a conserved cluster of basic amino acids at
the C-terminus of the cytoplasmic domain of GP2. Third,
Old World and New World arenaviruses also vary as a
Fig. 3. Cell surface expression of lymphocytic choriomeningitis virus glycoprotein (LCMVGP) in infected SRD12B and CHOK1 cells. SRD12B and CHOK1
cells were infected with LCMV at the indicated multiplicity of infection (MOI). After 48 h cells were detached and single cell suspensions prepared. (A)
Intracellular staining for LCMVNP. Cells were fixed, permeabilized, and stained with Cy5 directly conjugated monoclonal antibody (mAb) 113 to detect
LCMVNP. For flow cytometry, a FACSCalibur flow cytometer was used. In histograms, the y-axis represents cell numbers and the x-axis fluorescence
intensity (FL4-H for 113-Cy5). (B) Cell surface labeling of LCMVGP. Cell surface LCMVGP was detected with mAb 83.6 anti-LCMVGP2 and a
phycoerythrin (PE)-conjugated secondary antibody to mouse IgG. In histograms, the y-axis represents cell numbers and the x-axis fluorescence intensity
(FL2-H for anti-mouse-PE).
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group according to the amino acids composing the C-ter-
minus of GP2.
The GP precursor (GPC) of LCMV is cleaved at the
recognition motif RRLA by the subtilase SKI-1/S1P (Beyer
et al., 2003; this study). LCMV virions are assembled at the
plasma membrane; hence, we examined the relevance of
SKI-1/S1P cleavage for cell surface expression of GP and
its incorporation into virions. Cell surface biotinylation per-
formed on LCMV-infected cells revealed mainly cleaved
GP but also small amounts of uncleaved GP in the plasma
membrane, providing initial evidence that proteolytic pro-
cessing of GP may not be required for transport to the cell
surface. To address the relevance of SKI-1/S1P cleavage for
cell surface expression of GP in infected cells, flow cytom-
etry analysis on LCMV-infected S1P-deficient SRD12B
cells was performed. Cell surface labeling for GP correlated
directly with the degree of infection, as assessed by intra-
cellular staining for LCMVNP, demonstrating GP surface
expression in absence of cleavage. The detection of GP on
infected S1P-deficient cells is consistent with the efficient
cell surface expression of cleavage-deficient GP mutants in
transfected COS1 cells (Fig. 5) and in other mammalian cell
lines studied by Beyer et al. (2003).
Despite the presence of uncleaved GP at the surface of
infected cells, protein analysis of virion-like particles re-
leased from LCMV-infected SRD12B cells indicated that
uncleaved GP was inefficiently incorporated into virions.
These findings suggest that GP cleavage is likely a prereq-
uisite to incorporation into virions. Interestingly, reduced
incorporation of uncleaved GP into virions was also re-
ported with the closely related Old World arenavirus LFV
(Lenz et al., 2001). Similar to our findings with LCMV,
virion-like particles released from LFV-infected SRD12B
cells contained NP but no detectable GP. Since LCMVGP
and LFVGP show a high degree of sequence conservation
and are both cleaved by SKI-1/S1P (Lenz et al., 2001; Beyer
et al., 2003), the requirement of precursor cleavage for
incorporation of GP into virions is likely conserved between
and a requirement for Old World arenaviruses.
Several different viruses contain surface proteins that are
posttranslationally cleaved (reviewed by Klenk and Garten,
1994). In some but not all cases, cleavage has been shown
to be a requirement for infectivity. Similar to our findings
with LCMV, studies of the GP of human immunodeficiency
virus type 1 (HIV-1) demonstrated a requirement of GP
cleavage for incorporation into virions and infectivity, but
not for cell surface expression. Despite being transported to
the cell surface, cleavage-deficient mutants of HIV-1 GP
were not efficiently incorporated into virions and were un-
able to initiate cell-cell fusion or to mediate infection. In
contrast, in the fliovirus family proteolytic processing of GP
is not needed for production of infectious virus (Neumann et
al., 2002).
We also document here a clear correlation between GP
cleavage, the production of infectious LCMV particles, and
virus propagation in cell cultures. In the absence of GP
cleavage, limited quantities of infectious LCMV particles
were produced and propagation of the virus was restricted.
Since cleavage of LCMVGP by SKI-1/S1P occurs in an
intracellular compartment (Beyer et al., 2003) and no ex-
tracellular SKI-1/S1P activity has been described so far,
processing of LCMVGP at the cell surface or in the extra-
cellular space is unlikely. The intracellular site of cleavage,
together with the pivotal role of GP proteolytic processing
for infectivity likely contributes to the selection of a virion
assembly mechanism that favors the incorporation of
cleaved GP over uncleaved GP. The molecular reason for
the preferred incorporation of cleaved GP into virions is
currently not understood.
We also demonstrate that proteolytic processing of
LCMVGP critically depends on the cytoplasmic tail of GP2.
Deletion of the entire cytoplasmic domain or of the three
C-terminal basic amino acids KRR of GP2 did not affect
cell surface expression of GP but did result in lack of
cleavage and loss of function of GP, suggesting that alter-
ations in the cytoplasmic domain influence the structure and
the function of the ectodomain. There is precedent for al-
Fig. 4. The cytoplasmic domain of GP2 for lymphocytic choriomeningitis
virus (LCMV) is required for cleavage. (A) Schematic representation of the
LCMV glycoprotein (LCMVGP) deletion mutants: GP1 (white) and GP2
(black), and the transmembrane domain (gray box) are indicated. (B)
Expression of the LCMVGP mutants and wild-type LCMVGP. COS1 cells
were transfected with the LCMVGP variants LCMVGPD1 (lane 1),
LCMVGPD2 (2), LCMVGPRRAA (3), wild-type LCMVGP (4), and
EGFP (5). Cells were lysed 48 h after transfection, protein separated by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE),
and blotted to nitrocellulose. Membranes were probed for LCMVGP as
described in Fig. 1. Molecular mass standards are indicated. (C) Loss of
function of the LCMVGP mutants. HEK293 T cells were cotransfected
with LCMVGPD1 (D1), LCMVGPD2 (D2), LCMVGPRRAA (RRAA),
wild-type LCMVGP (ARM), VSVGP (VSV), and EGFP (GFP) in com-
bination with a plasmid containing the moloney leukemia virus (MLV) gag
and pol genes and a plasmid containing an MLV genome with an enhanced
green fluorescent protein (EGFP) reporter gene. Forty-eight hours after
cotransfection, MLV-PS titers in the supernatants were determined as
described in Fig. 2 (n  3; SD).
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terations in the cytoplasmic domain having effects on
ectodomain structure and function for other viral glycopro-
teins. Truncations of the cytoplasmic tails of several
paramyxovirus fusion proteins have a significant impact on
their biological activity (Sergel and Morrison, 1995; Yao
and Compans, 1995; Bagai and Lamb, 1996; Dutch and
Lamb, 2001; Tong et al., 2002; Seth et al., 2003). Deletions
in the cytoplasmic tails of measles virus F and H proteins
have varying effects on measles virus receptor binding and
fusion (Cathomen et al., 1998; Moll et al., 2002). Trunca-
tions in the cytoplasmic domains of the envelope glycopro-
teins of HIV-1 and HIV-2, as well as simian immunodefi-
ciency virus, also influence syncytium formation and fusion
activity (Earl et al., 1991; Gabuzda et al., 1992; Mulligan et
al., 1992; Ritter et al., 1993; Zingler and Littman, 1993;
Edwards et al., 2002). In toto, these findings are consistent
with a structural interdependence between the cytoplasmic
domains and the ectodomains of these GPs.
For LCMVGP, the deletion of the entire cytoplasmic
domain had no effect on cell surface expression, suggesting
that the cytoplasmic domain of LCMVGP is not needed for
transport to the cell surface. The effect of the C-terminal
truncation of LCMVGP on cleavage but not on transport we
found is reminiscent of the situation recently described for
the SV5 virus F protein where some mutations in the cyto-
plasmic domain prevented cleavage without affecting cell
surface expression (Seth et al., 2003).
While deletion of the entire cytoplasmic domain may
result in changes in the overall conformation of GP, it was
of interest to find lack of cleavage after deletion of only
three C-terminal amino acids of GP2. For this to occur, the
effects of the truncation of the cytoplasmic tail must be
transduced through the membrane to inhibit proteolytic
cleavage within the ectodomain of GP. One possibility is
that the cytoplasmic truncation affects oligomerization of
GP, which may be required for proper folding and process-
ing. To begin to test for this possibility, we analyzed the
C-terminal sequences of GP of LCMV and other arenavi-
ruses for the presence of sequence motifs known to be
involved in protein-protein interactions. Sequence compar-
ison revealed the presence of a conserved three amino acid
sequence WKR at the C-terminus of GP2, which was found
in Old World but not New World arenaviruses (Table 1). In
LCMV strains ARM53b and WE, an additional R is present
at the C-terminus. The deletion in LCMVGPD2 removes
amino acids KR from the WKR motif. WKR sequence
motifs are highly conserved in signal transducers and acti-
vators of transcription (STATs), a family of transcription
factors activated in a variety of cytokine signaling pathways
(Ilaria et al., 1999). WKR motifs were found to be crucial
for dimerization of STATs, a requirement for DNA binding
and activity in transcription. Interestingly, in the majority of
STATs, the WKR motif is followed by an R, resulting in the
WKRR motif (Ilaria et al., 1999; Fig. 1), which is found at
the C-termini of the GPs of LCMV ARM53b and WE. The
implication of WKR motifs in protein-protein interactions is
interesting. In analogy to its role in the dimerization of
STATs, WKR motifs in GP2 of Old World arenaviruses
may play a role to the oligomerization of GP. The partial
deletion of the C-terminal WKR motif in LCMVGPD2 may
result in disruption of the oligomeric structure of GP, which
may in turn affect folding of the ectodomain, and, as a
Fig. 5. Cell surface expression of lymphocytic choriomeningitis virus glycoprotein (LCMVGP) mutants in COS1 cells. COS1 cells were transfected with the
LCMVGP mutants LCMVGPD1 (D1), LCMVGPD2 (D2), LCMVGPRRAA (RRAA), wild-type LCMVGP (wt), and empty vector (mock) using Lipo-
fectamine. After 48 h cells were detached and single cell suspensions prepared. Cell surface LCMVGP was detected as described in Fig. 3. In dot-plots, the
y-axis represents forward scatter (FSC-H) and the x-axis fluorescence intensity (FL2-H for anti-mouse-PE). GP-positive cells appear in the lower right
quadrant and percentages are indicated.
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consequence, its proteolytic processing and biological func-
tion. Alternatively, the C-terminal WKR motif of LCMVGP
may be involved in binding to an as yet unknown host cell
factor that is crucial for its folding and processing.
Considering the pivotal role of GP cleavage by SKI-1/
S1P for virus production and dissemination during acute
and persistent infections with LCMV and the highly human
pathogenic LFV, attacking proteolytic processing with
drugs would seem a highly promising strategy. However,
since the SKI-1/S1P protease is involved in cholesterol
metabolism (Sakai et al., 1998), a mimetic would be needed
that would prevent cleavage of the virus GP but not affect
the host cell. Since the C-terminal truncation of only three
amino acids of the cytoplasmic domain prevents cleavage of
GP, this region may represent a more interesting drug target




Monoclonal antibodies (mAb) 113 (anti-LCMVNP),
83.6 (anti-LCMVGP), as well as polyclonal guinea-pig anti-
LCMV serum have been described (Buchmeier et al., 1981;
Weber and Buchmeier, 1988). Polyclonal mouse mAb
DM1A anti--tubulin was purchased from Sigma Chemical
Co., St Louis, MO. Cy5-conjugated mAb 113 was prepared
as described (Sevilla et al., 2000). Horseradish peroxidase
(HRP)-conjugated anti-mouse IgG and anti-guinea pig IgG
were from Pierce Chemical Co., Rockford, IL. Phyco-
erythrin (PE)-conjugated goat anti-mouse IgG was from
Jackson Immuno-Research Laboratory (West Grove, PA).
Cell cultures and viruses
COS1, BHK21, Vero, and HEK293T cells were main-
tained at 37°C, 5% (vol/vol) CO2, in DMEM (GibcoBRL,
Gaithersburg, MD) supplemented with 10% (vol/vol) fetal
calf serum (FCS), 100 U/ml penicillin, and 0.1 mg/ml strep-
tomycin. Chinese hamster ovary (CHO)-K1 cells were
grown at 37°C, 8% (vol/vol) CO2 in DMEM nutrient mix-
ture F12 Ham (GibcoBRL) supplemented with 10% (vol/
vol) FCS, 100 U/ml penicillin, and 0.1 mg/ml streptomycin.
The SKI-1/S1P-deficient CHOK1-derived cell line SRD12B
(Rawson et al., 1998) was maintained in the same medium
as CHOK1 cells with the addition of 5 g/ml cholesterol
(Sigma), 1 mM sodium mevalonate (Sigma), and 20 M
sodium oleate (Sigma).
LCMV Armstrong ARM53b is a triple plaque-purified
isolate of ARM CA 1371 (Dutko and Oldstone, 1983). Seed
stocks were prepared by growth in BHK-21 cells. Purified
virus stocks were produced and their titers determined as
described (Dutko and Oldstone, 1983; Ahmed et al., 1984).
For the analysis of the production of LCMV ARM 53b in
SRD12B, CHOK1, and BHK-21 cells, 2  105 cells were
plated per well of a six-well plate. After 24 h cells were
infected with ARM53b at a MOI of 0.1. Medium without
additional lipids was used to avoid potential interference of
the supplementary lipids with the infection process. Super-
natants of infected cells were analyzed at 24, 48, and 72 h
post infection for virus content by plaque titration on Vero
cells (Dutko and Oldstone, 1983).
For Western blot analysis of virus produced in SRD12B
and CHOK1 cells, 2  106 cells were plated in poly-L-
lysine-coated T75 tissue culture flasks (Nunc, Denmark)
and 24 h later infected with LCMV ARM53b (MOI  1).
Table 1
Sequence comparison of the C-terminal sequences of GP2 of Old World and New World arenavirusesa
Virus strain C-terminal sequence of GP2 Cleavage site GenBank
Old World arenaviruses
LCMV ARM53b VKTVWKRRb RRLA m20869
LCMV WE VKTIWKRRb RRLA aj297484
LFV ILP VPTKWKRb RRLL af181853
LFV IV Josiah VPVKWKRb RRLL j04324
LFV V AV VPVRWKRb RRLL af246121
LFV II Nigeria VPVKWKRb RRLL
af181854
LFV III Nigeria VPVRWKRb RRLL x52400
Mopeia LPTQWKRb RRLL m33879
New World arenaviruses
Oliveros (Clade C) VRWVKRSRb RRLQ u34248
Junin (Clade B) PTVWRRGHb RRSL u70799
Sabia (Clade B) PITWHKNHb RRPL u41071
Tacaribe (Clade B) PTIWHRRHb RTLK m20304
Pichinde (Clade A) YQRNLTNGb RKLL k02734
a The Old World arenaviruses lymphocytic choriomeningitis virus (LCMV), Lassa fever virus (LFV), and Mopeia contain a conserved sequence WKR at
or near the C-terminus of GP2. These viruses contain either an RRLA or an RRLL recognition site for cleavage. The New World arenaviruses Pichinde (clade
A), Junin, Sabia, and Tacaribe (clade B), and Oliveros (Clade C) lack the WKR sequence.
b Conserved C-terminal basic amino acids of GP2.
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After removal of the virus inoculum, cells were kept in their
specific media as described above. After 48 h, supernatants
were harvested and centrifuged at 1200 rpm for 20 min at
4°C. Cleared supernatants were layered on a 20% sucrose-
cushion [equal volume of 20% (wt/vol) sucrose in phos-
phate-buffered saline (PBS) and subjected to ultracentrifu-
gation in a SW41 rotor at 35,000 rpm for 2 h at 4°C.
Supernatants were carefully removed and pellets were sol-
ubilized by boiling for 10 min in sodium dodecyl sulfate–
polyaccylamide gel electrophoresis (SDS-PAGE) sample
buffer.
For detection of LCMVGP in virions produced by Vero
cells, cells were infected with LCMV ARM53b at MOIs of
0.01 and 0.1. After 40 h, supernatants were cleared by
centrifugation at 1,200 rpm for 20 min at 4°C, LCMV
virions precipitated with polyethylene glycol, and purified
by ultracentrifugation on a renografin-gradient as described
(Dutko and Oldstone, 1983).
Construction of recombinant LCMVGP variants
To construct the LCMVGP deletion mutants, fragments
GP3Ff-D1 and GP3Ff-D2 were amplified by polymerase
chain reaction (PCR) on the plasmid pC-LCMVGP, which
contains the full-length LCMVGP cDNA derived from
LCMV ARM53b cloned into the pcAGGS vector. The fol-
lowing cDNA fragments generated by PCR were inserted
into pC-LCMVGP: LCMVGPD1 (462–498): GP3Ff-D1
digested with KpnI and XmaI. LCMVGPD2 (496–498):
GP3Ff-D2 digested with KpnI and XmaI.




The construct pC-LCMVGPRRAA containing full-
length LCMVGP (ARM53b) containing the mutations
R262A and R263A, the construct pC-VSVGP containing
the GP of vesicular stromatitis virus (VSV), as well as the
construct pC-EGFP containing the cDNA of enhanced
green fluorescent protein (EGFP) were kindly provided by
Juan-Carlos de la Torre (The Scripps Research Institute).
Transfection and expression of recombinant proteins
COS1, SRD12B, and CHOK1 cells were transfected with
the expression vectors by using Lipofectamine (GibcoBRL);
2  105 cells per well were plated in six-well plates and
kept at 37°C, 5% (8% for SRD12B, CHOK1) (vol/vol) CO2
for 16 h; 2 g of plasmid DNA was diluted in 100 l of
Optimem (GibcoBRL) mixed with 10 l of Lipofectamine
dissolved in 100 l of Optimem. The DNA/Lipofectamine
mixture was incubated at room temperature for 20 min and
then diluted to 1 ml with Optimem. Cells were washed three
times with Optimem prior to addition of the DNA/Lipo-
fectamine mixture. Cultures were incubated for 5 h at 37°C,
5% (vol/vol) CO2, the DNA/Lipofectamine removed and
fresh medium added. Cells were kept for 24–48 h in 5%
(8% for SRD12B, CHOK1) (vol/vol) CO2. Transfections
with the pC-EGFP reporter construct resulted in 60–70%
transfected cells in the case of COS1 and 40–50% in the
case of SRD12B, and CHOK1 cells.
Biotinylation of cell surface proteins
For cell surface biotinylation assay, Vero cells (105 cells/
well) were plated in poly-L-lysine-pretreated six-well plates.
When cells reached 20% confluency they were infected with
LCMV ARM53b at an MOI of 0, 0.001, 0.01, or 0.1 in an
inoculum of 1 ml of medium. After 1 h at 37°C, 5%
(vol/vol) CO2, the infecting inoculum was removed, cells
washed three times with medium and incubated for 40 h
prior to cell surface labeling. For cell surface biotinylation,
cells were washed four times in PBS supplemented with 1
mM MgCl2 and 0.1 mM CaCl2 (PBS-CM). Cells were kept
on ice for 10 min and 1 ml of 1 mM NHS-X-biotin (Cal-
biochem) diluted in cold PBS-CM added as described by
Gonzalez-Dunia et al. (1997). The reagent was applied
twice for 20 min on ice with gentle shaking, after which free
biotin was quenched by removing NHS-X-biotin and adding
cold 50 mM glycine, 150 mM NaCl, 1 mM MgCl2, 0.1 mM
CaCl2, pH 8.0, for 10 min. Cells were then washed twice in
PBS-CM and lysed in 1 ml of lysis buffer/well [1% (wt/vol)
Triton X-100, 1% (wt/vol) sodium deoxycholate 0.1% (wt/
vol) SDS, 50 mM Tris/HCl, pH 8.0, with 1 mM PMSF, and
protease inhibitor complete (Roche)]. The resultant lysates
were cleared by centrifugation at 14,000 rpm, 4°C, for 10
min. To separate biotinylated proteins, 0.5 ml of lysate were
incubated with 20 l/ml of lysate streptavidin coupled to
agarose (Sigma) and incubated in the cold for 12 h on a
head-over shaker. The matrix was washed twice with lysis
buffer and three times with PBS-CM and bound proteins
eluted by boiling in SDS-PAGE sample buffer. Total pro-
tein was isolated from 0.5 ml of lysate (Wessel and Fluegge,
1984). Samples were then analyzed in Western blot using
mAbs 86.3 to LCMVGP2 and DM1A to -tubulin.
Immunoblotting
For total cell lysates, cells were washed twice with PBS
and lysed in preheated (95°C) SDS-PAGE sample buffer:
2% (wt/vol) SDS, 50 mM Tris/HCl, pH 6.8, 100 mM di-
thiothreitol (DTT). For isolation of total protein, cells were
washed twice with PBS and lysed in 1% (wt/vol) Triton
X-100, 1% (wt/vol) CHAPS, 0.1% (wt/vol) SDS, 5 mM
EDTA, 1 mM PMSF, 1 mM iodacetamide, 100 mM NaCl,
50 mM Tris/HCl, pH 7.5 Proteins were then precipitated
(Wessel and Fluegge, 1984) and dissolved in SDS-PAGE
sample buffer by boiling for 5 min. Proteins were separated
by gel electrophoresis and transferred to nitrocellulose. Af-
ter blocking in 5% (wt/vol) skim milk powder in PBS,
membranes were incubated with the primary antibody (mAb
83.6 anti-LCMVGP2 in a dilution of 1:1000, mAb DM1A
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anti--tubulin 1:2000, and polyclonal guinea pig anti-
LCMV serum 1:500) in 2% (wt/vol) skim milk powder,
PBS, for 12 h at 6°C. After several washes in PBS, 0.1%
(wt/vol) Tween 20 (PBST), the secondary antibodies, goat
anti-mouse IgG coupled to peroxidase or goat anti-guinea
pig IgG coupled to peroxidase, were applied 1:5000 in
PBST for 1 h at room temperature. Blots were developed by
enhanced chemiluminescence (ECL) by using Super Signal
West Pico ECL Substrate (Pierce) and signals were re-
corded on autoradiographic film (Kodak, Rochester, NY).
Densitometric analysis was performed with a Storm 860
scanner using ImageQuant software.
Generation of pseudotyped retroviral vectors
Pseudotyped MLV virions (MLV-PS) were generated by
using the strategy described by Soneoka et al. (1995).
Briefly, a pcAGGS expression plasmid containing the GP in
question, a plasmid containing the MLV gag and pol genes,
and a plasmid containing a packable MLV genome with an
EGFP reporter gene were cotransfected into HEK293T cells
using calcium phosphate. For cotransfection in SRD12B,
CHOK1, and COS1 cells, Lipofectamine was used. Forty-
eight hours after transfection, cell supernatants were har-
vested and centrifuged for 15 min at 4000 rpm. Supernatants
were not frozen but kept on ice for a maximum of 12 h prior
to determination of titers. For titration of pseudotyped vi-
ruses, monolayers of Vero cells were grown in 96-well
plates and infected with 50 l of serially diluted superna-
tants. After a 1-h incubation period, the inoculum was
removed, cells washed twice with PBS, and fresh culture
medium added. At 24 h post infection, EGFP-expressing
cells were counted under an inverted fluorescence micro-
scope. Foci of EGFP-expressing cells were scored as infec-
tious units (pfu).
Flow cytometry
SRD12B and CHOK1 cells (2  105 cells/well) were
plated in six-well plates and infected with LCMV ARM53b
at MOI of 0, 0.001, 0.01, 0.1, and 1 as described above.
COS1 cells were transfected with the LCMVGP variants
LCMVGPD1, LCMVGPD2, and wild-type LCMVGP using
Lipofectamine as outlined above. To reduce cytotoxicity,
cells were exposed to the Lipofectamine/DNA mixture for
only 1 h, resulting in circa 10% transfected cells, as assessed
by a green fluorescence protein (GFP) reporter construct.
Forty-eight hours post infection/transfection, cells were de-
tached with enzyme-free cell dissociation solution (Sigma)
and resuspended in FACS buffer [1% (vol/vol) fetal bovine
serum, 0.1% (wt/vol) sodium azide, PBS]. Intracellular
staining for LCMVNP using mAb 113 anti-LCMVNP was
performed as described (Sevilla et al., 2000). For cell surface
staining for LCMVGP, cells were incubated with mAb 83.6
anti-LCMVGP2 (1:200 in FACS buffer) for 1 h on ice. Cells
were then washed three times in FACS buffer and labeled
with a PE-conjugated goat-anti-mouse IgG (1:200 in FACS
buffer) for 45 min on ice in the dark. After three wash-steps
in FACS buffer, cells were fixed with 4% (wt/vol) parafor-
maldehyde, PBS, for 10 min at room temperature, washed
three times with PBS, and analyzed with a FACSCalibur
flow cytometer (Becton Dickinson, San Jose CA) using Cell
Quest or FlowJo software.
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